Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK7 | P49862 | 5/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 5/20 | 0.32 |
| ▸ | ACHE | P22303 | 4/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.31 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.31 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30977770 | 0.93 | KLK7 (0.34) | KLK7BCHEACHETDP1CACNA1F | |
| SCHEMBL30977769 | 0.89 | KLK7 (0.33) | KLK7BCHEACHETDP1CACNA1F | |
| SCHEMBL30977717 | 0.88 | KLK7 (0.37) | KLK7BCHEACHETDP1PPARG | |
| SCHEMBL30977707 | 0.88 | KLK7 (0.37) | KLK7BCHEACHETDP1PPARG | |
| SCHEMBL30977747 | 0.88 | KLK7 (0.32) | KLK7CTSKTDP1PPARG | |
| SCHEMBL30977742 | 0.87 | KLK7 (0.36) | KLK7BCHETDP1PPARG | |
| SCHEMBL30977701 | 0.85 | KLK7 (0.34) | KLK7BCHEACHETDP1CACNA1F | |
| SCHEMBL30977766 | 0.84 | CTSK (0.33) | CTSKBCHEACHE | |
| SCHEMBL30837885 | 0.83 | TLR2 (0.34) | BCHEACHEPPARG | |
| SCHEMBL30977728 | 0.81 | BCHE (0.32) | CTSKBCHEACHECACNA1FCACNA1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638417-A1 | SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS AND OTHER THERAPEUTIC AGENTS | Nanovation Therapeutics Inc. (CA) | 2025-10-29 | — | — | EP | disclosed |
| WO-2024130421-A1 | SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS AND OTHER THERAPEUTIC AGENTS | NANOVATION THERAPEUTICS INC. (CA) | 2024-06-27 | — | — | WO | disclosed |